AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Tranostat Injection

Prescription Icon
Prescription Required

Marketer

Ozone Pharmaceuticals Ltd

Salt Composition

Tranexamic Acid (500mg)

Overview Tranostat Injection

Hemostatic Injection is indicated for hemorrhage management. It aids in preventing or minimizing blood loss during procedures such as dental extractions, menorrhagia, abnormal uterine bleeding, epistaxis, and surgeries involving the oral cavity, prostate, or bladder. This medication, an antifibrinolytic agent, functions by inhibiting clot dissolution, thereby controlling bleeding. Administration must be performed by a qualified healthcare provider. Contraindicated in individuals with known hypersensitivity. Frequently reported adverse effects encompass injection site reactions, fatigue, musculoskeletal discomfort, and rhinorrhea. Prior cardiac surgery or renal impairment should be disclosed to your physician. Use is considered safe during pregnancy and lactation, and poses no significant risk to patients with hepatic dysfunction.

Primary Ingredients of Tranostat Injection

No text provided to rephrase.

Uses of Tranostat Injection

Managing Hemorrhage

Major Benefits of Tranostat Injection:

Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Tranostat Injection:

  • Joint pain
  • Headache
  • Back pain
  • Vomiting
  • Nausea
  • Abdominal pain
  • Diarrhea
  • Muscle cramp
  • Anemia (low number of red blood cells)
  • Lightheadedness

How to use Tranostat Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Tranostat Injection works:

Tranostat Injection, an antifibrinolytic agent, inhibits fibrinolysis, thus preventing clot dissolution and managing excessive hemorrhage associated with menstruation or post-operative procedures.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concomitant use of Tranostat Injection and alcohol may lead to significant somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on Tranostat Injection use in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Tranostat Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Tranostat Injection's impact on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Exercise caution when administering Tranostat Injection to individuals with impaired renal function. Dosage modification for Tranostat Injection may be necessary. Physician consultation is recommended.

LiverLiverSAFE IF PRESCRIBED

Tranostat Injection appears safe for use in individuals with hepatic impairment. Available evidence indicates dose modification may not be necessary for this patient population. Physician consultation is advised.

What if you forget to take Tranostat Injection :

Omit a Tranostat Injection dose? Seek your physician's advice.

Facts to Know About Tranostat Injection

LabelValue
Chemical Type Amino Acid and Peptide Analogs
Developing Habits No.
Treatment Category KINSHIP

FAQs on Tranostat Injection

Tranostat Injection must be administered intravenously; intramuscular injection is contraindicated due to the risk of adverse reactions.
All medications carry potential side effects, though these are less likely when taken as prescribed. The benefits typically outweigh the risks. However, Tranostat Injection may rarely cause serious, potentially dangerous side effects, including anaphylaxis (characterized by rash, breathing difficulties, and facial/oral swelling), blood clots, or vision problems. Always consult your doctor before use and adhere strictly to their instructions.
Tranostat Injection helps stop bleeding by promoting blood clotting. Rarely, this may cause deep vein thrombosis (DVT), a blood clot in the leg. Studies suggest other factors may contribute to this risk, which appears higher in women using Tranostat. Consult your doctor before use and follow all instructions carefully.
Prolonged Tranostat Injection treatment may affect your color vision. Regular eye exams are therefore recommended, and any vision changes should be reported to your doctor immediately. They may discontinue the medication and prescribe an alternative if necessary.
Tranostat Injection accelerates blood clotting, though rarely causing potentially fatal blood clots in the lungs (pulmonary embolism). While uncommon, pulmonary embolism risk increases with overdose, prolonged immobility, or pre-existing conditions. Other factors may also contribute to this elevated risk.
Tranostat Injection should be taken with or without food, and swallowed whole with water; do not crush or chew.
Dosage and treatment length for this medication vary depending on the condition. For heavy menstrual bleeding, it's typically prescribed for five days. For other conditions, the duration may be shorter or longer, as determined by the doctor.
Tranostat Injection does not impact fertility. Prescribed for heavy menstrual bleeding, it shows no evidence of interfering with ovulation. Consequently, it's not a contraceptive and won't affect your ability to conceive.
Tranostat Injection can effectively stop nosebleeds by promoting blood clotting. For persistent nosebleeds, a week-long course of the injection may be necessary.
Tranostat Injection
54
MRP 63
14% off